Table 1 Clinical symptoms with regard to the gastrointestinal tract in COVID-19 IBD and non-IBD patients.54,55
Clinical symptom | COVID-19 patient number | IBD COVID-19 | Non-IBD COVID-19 | Reference | |
|---|---|---|---|---|---|
Nausea, vomiting | IBD = 232 Control = 19.776 | 10.77% | 4.31% | P < 0.01 | |
Diarrhea | IBD = 232 Control = 19.776 | 8.19% | 5.14% | P < 0.01 | |
IBD = 80 Control = 160 | 45% | 19% | P < 0.01 | ||
Abdominal pain | IBD = 232 Control = 19.776 | 7.75% | 2.7% | P < 0.01 | |
IBD = 80 Control = 160 | 20% | 5% | P < 0.01 |
